Phase I clinical trial of hepatic arterial infusion of cisplatin in combination with intravenous liposomal doxorubicin in patients with advanced cancer and dominant liver involvement

Author： Tsimberidou Apostolia   Moulder Stacy   Fu Siqing   Wen Sijin   Naing Aung   Bedikian Agop   Daring Shawn   Uehara Cynthia   Ng Chaan   Wallace Michael   Camacho Luis   Kurzrock Razelle  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.66, Iss.6, 2010-11, pp. : 1087-1093

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Clinical Phase I Trial of S-1 in the Combination with DOC Using Super-Selective Intra-Arterial Infusion with Oral Cancer

By Ueyama Yoshiya   Okafuji Masaki   Harada Kouzi   Mano Takamitsu   Mihara Mariko   Uchida Kenichiro   Horinaga Daiju   Wada Noriko  

Japanese Journal of Cancer and Chemotherapy, Vol. 36, Iss. 3, 2009-03 ,pp. : 395-399

Sunmedia

Access to resources Recommend Favorite

Phase II Trial of Intraperitoneal Cisplatin with Intravenous Doxorubicin and Cyclophosphamide in Previously Untreated Patients with Advanced Ovarian Cancer-Long-Term Follow-Up

By Morgan R.J.   Braly P.   Cecchi G.   Leong L.   Shibata S.   Margolin K.   Somlo G.   McNamara M.   Longmate J.   Schinke S.   Raschko J.   Nagasawa S.   Kogut N.   Parker P.   Stein A.   Cho J.   Smith E.   Coluzzi P.   Najera L.   Johnson D.   Womack E.   Doroshow J.H.  

Gynecologic Oncology, Vol. 75, Iss. 3, 1999-12 ,pp. : 419-426

Elsevier

Access to resources Recommend Favorite

Phase I Trial of Pegylated Liposomal Doxorubicin with Hyperthermic Intraperitoneal Chemotherapy in Patients Undergoing Cytoreduction for Advanced Intra-abdominal Malignancy

By Harrison Lawrence   Bryan Margarette   Pliner Lilian   Saunders Tracie  

Annals of Surgical Oncology, Vol. 15, Iss. 5, 2008-05 ,pp. : 1407-1413

Springer Publishing Company

Access to resources Recommend Favorite

Phase II trial of pegylated liposomal doxorubicin (Caelyx™) plus Gemcitabine in chemotherapeutically pretreated patients with advanced breast cancer

By Ulrich-Pur Herbert   Kornek Gabriela   Haider Karin   Kwasny Werner   Payrits Thomas   Dworan Nina   Vormittag Laurenz   Depisch Dieter   Lang Fritz   Scheithauer Werner  

Acta Oncologica, Vol. 46, Iss. 2, 2007-01 ,pp. : 208-213

Informa Healthcare

Access to resources Recommend Favorite

Phase I Trial of Etoposide, Doxorubicin and Cisplatin (EAP) in Combination with GM-CSF

By Ford P.A.   Arbuck S.G.   Minniti C.   Miller L.L.   DeMaria D.   O'Dwyer P.J.  

European Journal of Cancer, Vol. 32, Iss. 4, 1996-04 ,pp. : 631-635

Elsevier

Access to resources Recommend Favorite